Enzymotec

A specialty chemicals company that developed, manufactured, and marketed innovative bio-active lipid ingredients and nutritional products.

Health Tech & Life Sciences
Acquired by Frutarom
Acquired Migdal HaEmek, Israel Founded 1998
Last updated 2026-07-26
Total raised
$36.9M
Last: Undisclosed Round 2017-08
Stage
Acquired
Founded
1998
Headcount
124
HQ
Migdal HaEmek, Israel
Sector
Health Tech & Life Sciences

About

Enzymotec is a biotechnology company that develops and produces biofunctional ingredients designed to address the health needs of everyone from babies to senior citizens. Enzymotecs nutrition and pharmaceutical business segments leverage the companys expertise in lipids. The nutrition segment manufactures lipid-based ingredients for use in products such as infant formula, nutritional supplements, and other dietary needs. The companys VAYA pharmaceutical segment makes and sells branded lipid-based medical foods for the dietary management of medical disorders and common diseases, including for the cardiovascular and neurological markets. Enzymotec is a fully owned subsidiary of Frutarom.

Funding history · 6 rounds · $36.9M total

2017-07
C Round $12.9M
★ Frutarom
2013-08
Follow-on PO Undisclosed
2011-12
B Round $10.0M
★ TPY Capital
2009-01
A Round $11.0M
★ Galam★ Ofer Hi-Tech★ Arancia International★ Vintage Investment Partners★ Millennium II Materials Technology Fund
2001-05
Seed $2.0M
★ Galam★ MMT Funds
1999-12
Pre-Seed $1.0M
★ MMT Funds

Q&A

What is Enzymotec's current status?
Enzymotec was acquired by Frutarom in January 2018 and is currently inactive.
When was Enzymotec founded?
Enzymotec was founded in March 1998.
What is Enzymotec's primary business?
Enzymotec is a specialty chemicals company that developed, manufactured, and marketed innovative bio-active lipid ingredients and nutritional products.
How many employees does Enzymotec have?
Enzymotec has 51–200 employees.
What was the total amount of funding raised by Enzymotec?
Enzymotec raised a total of $100,400,000 across various funding rounds.
When did Enzymotec complete its B Round funding?
Enzymotec completed a B Round funding in February 2009, with participation from Ofer Hi-Tech and Arancia International.
When did Enzymotec conduct a Public Offering?
Enzymotec had a Public Offering in October 2013, raising $63,500,000.
Who acquired Enzymotec and for how much?
Enzymotec was acquired by Frutarom in January 2018 for $210,000,000.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2C

Tags

seniorsadhdnutritionbiotechnologysupplementspharmaceuticalsbabiesfoodtechnovel-ingredientsfood-and-beveragepharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitewww.enzymotec.com
LinkedInlinkedin.com/company/411959
YouTubeyoutube.com/channel/UCTXtDL_Ly0EbjVO9o76cDsA
Wikipediaen.wikipedia.org/wiki/Enzymotec
Wikidatawikidata.org/wiki/Q7917558

Identifiers & details

Legal nameEnzymotec Ltd.
Founded1998-3
Employees (exact)124
OfficesMorristown; Bentleigh; China
Status reasonAcquired (Inactive) by Frutarom on Jan 2018 - closed due to acquisition
Wikidata QIDQ7917558

Acquisitions & public offerings

Acquired by Frutarom 2018-01 $210.0M

Radar intelligence

Patents

EPO49

Publications (Crossref)

Works8

Web history (Wayback)

Domainenzymotec.com

Wikidata

QIDQ7917558

Certificate / subdomain footprint

Subdomains12

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)512609249
Statusמחוסלת עקב מיזוג — CLOSED
Corp typeישראלית חברה ציבורית
Incorporated1998-03-08
Purposeלעסוק בסוגי עיסוק שפורטו בתקנון
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2017
Active charges / liens0
Registry events0
Registered addressאיזור תעשייה שגיא 0 מגדל העמק